Ectopic activation of the Wnt signaling pathway is highly oncogenic for many human tissues. Here, we show that ectopic Wnt signaling increases the effective stem cell activity in mouse mammary glands in vivo. Furthermore, Wnt effectors induce the accumulation of mouse mammary epithelial progenitors (assayed by Hoechst dye exclusion, a surrogate stem cell marker, side population cells) both in vivo and in vitro. The longevity of stem cells makes them good candidate tumor precursors, and we propose that Wnt-induced progenitor amplification is likely to be key to tumor initiation. In support of this notion, mammary glands from a tumor-resistant strain of mice (carrying a null mutation in syndecan-1) contain fewer side population cells. When this strain is crossed to mice that overexpress effectors of the ␤-catenin͞T cell factor Wnt pathway, the amplification of progenitors is reduced, together with all subsequent events of tumor development. We propose that the growth dynamic of the stem cell fraction is a major determinant of tumor susceptibility.
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Wnt-1 ͉ ␤-catenin ͉ syndecan-1 ͉ heparan sulfate proteoglycan ͉ mouse mammary epithelial cells T he majority of cells in adult epithelia are thought to have a limited intrinsic division potential. They are the daughters of a minor population of progenitor cells that are relatively undifferentiated and long-lived (or immortal). This longevity is thought to facilitate the accumulation of oncogenic genetic mutations and make transformation more likely.
In mouse mammary gland, the presence of primitive progenitors has been implied by serial transplantation studies of mammary epithelial cells (1) . Thus, outgrowth of a full mammary branching tree from limiting dilutions of mammary epithelial transplants is considered to be an assay of clonal stem cell function (2) , and this activity is depleted after four to six transplants. Data obtained from the study of hematopoietic stem cells has served to define molecular and functional properties that are shared by other somatic stem cells. Thus, a progenitorenriched fraction [so-called side population (SP) cells] was defined by Hoechst-33342 dye efflux (conferred by the ABC transporter Bcrp1) (3, 4) . When SP fractions were purified from mammary epithelial cell populations, they were shown to be enriched for BrdUrd label-retaining cells, to show low expression of differentiated markers (such as cytokeratins 14 and 19) and to express higher telomerase activity. These SP cells, when transplanted into cleared mammary fat pads, could reconstitute both myoepithelial and luminal mammary lineages in vivo (5, 6) .
It is likely that stem cells have unique modes of growth factor reception and signal transduction (7) (8) (9) , especially with regard to pathways that regulate asymmetric cell division, a property associated with stem cell self-renewal. In model organisms, such as Caenorhabditis elegans and Drosophila, Wnt, Notch, and Hedgehog pathways are key to regulating asymmetric divisions. These same pathways are oncogenic when misregulated in mammalian tissues (10) . Thus, many human tumors contain mutations that serve to stabilize the Wnt effector ␤-catenin (11) . Clues to the mechanism underlying the oncogenicity of ectopic Wnt signaling have been gleaned from the reciprocal effects that loss-and gain-of-function Wnt signaling mutations have on morphologic compartments thought to contain somatic stem cells. More specifically, a mutation in the Wnt signaling pathway in intestine (Tcf4 Ϫ/Ϫ ) eliminates the crypt-associated stem cell population (12) , whereas gain-of-function mutations of Wnt signaling [(Apc min or ⌬N89␤-catenin (⌬N␤cat)] induce hyperplastic development and tumors (13, 14) . Similarly, if Wnt signaling is inhibited in mouse skin, hair follicle development is eliminated (hair follicles are a source of epidermal stem cell activity) (15) . On the other hand, gain of function of Wnt signaling (⌬N␤cat expressed in basal keratinocytes) induces follicular hyperplasia and pilomatricoma tumors (16, 17) . More recently, the size of the hematopoietic stem cell pool has been shown to be directly regulated by Wnt signaling (18) .
Here, we test whether mammary progenitors are modulated by Wnt signaling. This hypothesis was based on the observation that Wnt-1-induced tumors comprise cells from both mammary lineages, suggesting that the tumor precursor is a bipotential progenitor. We find that functional progenitor activity is indeed elevated, and that the degree of accumulation of SP cells directly correlates with the risk of tumor development. Immunocytochemistry of Mammary Tissues. Mammary tissues were paraformaldehyde-fixed and embedded, and tissues were processed for antigen retrieval as specified by Zymed (heat-induced epitope retrieval). Sections were incubated in antibodies as follows: anti-Muc1 [CT2 Armenian Hamster monoclonal antibody; gift from S. Gendler (Mayo Clinic, Scottsdale, AZ)], FITC secondary antibody (catalog no. 127-095-160, Jackson ImmunoResearch), and Cy3 anti-smooth muscle actin (SMA) (clone 1C4, Sigma). were preplated (to remove fibroblasts) for 20 min in DMEM͞ F12 plus 10% FBS and insulin (10 g͞ml), washed twice with PBS, and incubated with proteolytic enzymes once more to enrich the yield of single cells [2 ml of F12 media plus 4 mg/ml collagenase͞150 g/ml hyaluronidase (catalog no. H-4272, Sigma)͞5 mg/ml dispase type II (catalog no. 165859, Roche)͞50 units/ml DNase I (catalog no. 104132, Roche) for 5 min at 37°C with trituration, followed by 1 ml of 0.05% trypsin plus 0.05% EDTA (GIBCO͞BRL) for 5 (22) . Cells were cultured with purified proteins for 60 h before they were harvested and labeled with Hoecsht dye as described above.
Materials and Methods
Transplantation of Cleared Mammary Fat Pads. MECs from ⌬N␤cat mice or FVB control littermates, 2-3 months old, were preplated and used to inoculate fat pads either with (experiment 1) or without (experiment 2) further enzymatic digestion (as above). Cells for transplantation were counted, suspended in DMEM plus 2% FBS with 5 g͞ml Matrigel (catalog no. 354234, Becton Dickinson) at 4°C together with loading dye (final concentration: 5% glycerol͞0.5% trypan blue͞25 mM Hepes), and inoculated in a 1-l volume containing 1,000-50,000 cells per l. Eight to 12 weeks after transplantation, fat pads were dissected, processed, and stained with carmine as described in ref. 19 .
Results

Wnt-1-Induced Tumors Are Aggressive but Contain Differentiated
Cells of Both Mammary Lineages. Differentiated adenocarcinomas emerge in a highly concerted manner as solitary, rapidly growing tumors within mammary glands that are systemically hyperplastic in response to the expression of the [MMTV-LTR]-driven Wnt1 oncogene (23, 24) . Other groups have noticed that SMApositive cells coexist with another cytokeratin 8-positive epithelial cell type in these tumors (23, 25) , implying that both myoepithelial and luminal cell lineages persist. We tested for expression of molecular markers of these two lineages in hyperplastic [MMTV-Wnt1] transgenic mammary glands and found that their expression was inhibited in overtly hyperplastic ductal zones (Fig. 1B) . In contrast, in Wnt1-induced tumors, differentiated cells from both lineages were represented throughout (Fig.  1C) . The number of SMA-positive cells varied between 10% and 65%; the number of Muc1-positive cells was between 20% and 55%. No cell appeared to express both markers, and a minor subpopulation expressed neither (7-17%). Tumors induced by ⌬N␤cat also contain both mammary lineages (Fig. 1C) . Tumors that arise in the TgN(Wnt1)1Hev strain have been shown to be clonal (or pseudoclonal) by retroviral tagging (26, 27) , and more recently loss of heterozygosity at the PTEN locus was shown to be shared by both myoepithelial and luminal lineages (28) . We conclude that the most likely precursor of Wnt1 and ⌬N␤cat-induced tumors is a bipotential stem cell, and we propose that dysregulation of this subpopulation will be evident early during tumor initiation. (29, 30) . Therefore, although SP cell fractions from several tissues are enriched in progenitors and there is no example to date of stem cell activity residing outside this fraction, all SP cells do not have equal (or perhaps any) stem cell potential (4) . With these caveats in mind, we applied dye efflux as a surrogate stem cell marker.
SP-Enriched Fractions Are Increased in Mammary Glands of MMTV-
MECs from virgin, 2-to 3-month-old females were isolated, trypsinized to obtain single cells, labeled with Hoechst dye, and analyzed by flow cytometry (Fig. 2) . We found that control littermate glands contained between 0.5% and 2.0% SP cells; whereas in the Wnt-1-induced hyperplastic gland, that fraction increased by 2.5-to 3.0-fold ( Fig. 2 A and C) . Similarly, but more dramatically, the accumulation of SP cells in MMTV-⌬N␤cat transgenic mammary glands was 9-fold ( Fig. 2 A and C) . Although the MMTV promoter is not entirely mammary epithelial cell-specific, we showed that the relative accumulation of SP cells was not hematopoietic in origin (supporting information, which is published on the PNAS web site). The glandular hyperplasia that was associated with these SP profiles is shown in Fig. 2B . Interestingly, in tumors from both mouse strains, the progenitor fraction reproducibly declined to relatively normal levels ( Fig. 2 A and C) , although the mitotic index increased (data not shown).
Ectopic Wnt Ligands Increase the SP Fraction in the MEC Population
After 3 Days of Primary Culture. In transgenic glands after 10 weeks of development in vivo, measurement of progenitor fractions can only be considered to be a distal effect of ectopic Wnt effector treatment. To test whether Wnt effectors were inducing this progenitor accumulation as a proximal, direct effect, we tested whether incubation of short-term, primary MEC cultures in soluble Wnt ligands affected the SP fraction. This experiment was performed by using two sources of the soluble Wnt ligand Wnt3A. Wnt3A falls into the transforming class of Wnt ligands (like Wnt1) and induces transactivation of T cell factor͞␤-catenin reporters in most cell types (including these primary mammary epithelial cell cultures (19) . Either a crude source of Wnt3A (conditioned medium from Wnt3A-transfected L cells; data not shown) or a relatively pure source of Wnt3A (a commercial source derived by expression in baculovirus; Fig. 3 ) were added to cultures in the presence or absence of the canonical Wnt-signaling pathway inhibitor dkk1 (31) . Wnt3A increased the fraction of SP cells by 70% but did not affect the growth of the total mammary cell population (Fig. 3 B and C) . Epidermal growth factor also maintains the SP cell fraction in these MEC cultures, and the addition of Wnt3A in the presence of epidermal growth factor had no additional effect, suggesting that these two factors are functionally redundant (data not shown). We could also show that the Wnt3A-induced increase was specifically inhibited by the addition of dkk1, and we conclude that Wnt3A-induced canonical signaling specifically induces the growth or survival of SP cells in primary culture.
Cells from ⌬N␤cat Transgenic Glands Colonize Cleared Mammary Fat
Pads More Efficiently Than Control Cells. The progenitor activity of SP cells is difficult to test directly, probably because of the toxicity of Hoechst dye binding and flow cytometric MECs.
Therefore, we chose to transfer cells from 10-week-old ⌬N␤cat transgenic glands by limiting dilution (1,000-50,000) into cleared fat pads of 3-week-old congenic recipients to measure their functional progenitor capacity (Fig. 4) . At this age, the donor glands were not substantially hyperplastic. At all cell numbers tested, more glands were colonized after transfer of ⌬N␤cat-expressing MECs, and the outgrowths showed exacerbated hyperplastic development. We conclude that the increased SP fraction observed in ⌬N␤cat transgenic MECs does indeed reflect increased functional stem cell activity. 
Sdc1
Ϫ/Ϫ mice resist Wnt1-and ⌬N␤cat-induced tumor development (19, 20) . Although we predicted that the Sdc1 heparan sulfate proteoglycan would be a coreceptor for the Wnt-Fz signaling complex (32), we showed instead that these gene products interacted only indirectly (19) . In the absence of Sdc1, a Wnt-responsive cell population was missing. Furthermore, we noticed that not only was the hyperplastic response to Wnt1 or ⌬N␤cat reduced but also that the normal adult Sdc1 Ϫ/Ϫ mammary tree was hypomorphic. These data suggested that the effect of Sdc1 deficiency was to alter mammary development and to create a mammary population resistant to Wnt effectordependent tumor induction.
To better describe the hypomorphic development in Sdc1 Ϫ/Ϫ mammary glands, we scored mammary gland complexity in juvenile and adult mice. Morphometric analysis showed that the branching complexity of adult glands was decreased ( Fig. 5 A and  C) . Because adult branching complexity is a function of terminal end bud activity during juvenile ductal extension, we assessed mammary morphogenesis at 4 weeks of age, and found an Ϸ50% decrease in terminal end bud number ( Fig. 5 A and B) . We propose that hypomorphic development is likely to be associated with changes in the progenitor fraction of Sdc1 Ϫ/Ϫ glands and, therefore, assayed SP cells from 4-to 6-month-old virgins. The SP fraction was reduced by 60% (Fig. 5D) . Thus, hyperplastic development and progenitor number are raised in mammary glands that overexpress Wnt effectors and are reduced in Sdc1 Ϫ/Ϫ mice that resist Wnt-induced tumor development.
The Null Allele of Sdc1 and Wnt Effector Transgenes Oppose Each
Other to Regulate Mammary Progenitor Division. We propose, therefore, that Sdc1 and Wnt signaling both regulate mammary progenitor cell function. To test this hypothesis, we assayed the progenitor population in ⌬N␤cat ϩ/Ϫ glands in the absence of Sdc1 expression (Fig. 6) . The SP population was reduced by 66% in Sdc1 Ϫ/Ϫ glands even on this mixed-strain background. When ⌬N␤cat was expressed in the absence of Sdc1, the fold increase in the SP fraction was also reduced by half, and this decrease correlated with reduced tumor incidence and increased tumor latency (19) . This finding is consistent with the proposal that both Sdc1 and Wnt modulate the growth or differentiation of this progenitor population.
Discussion
We have found that mammary stem cell activity is increased in transgenic glands from [MMTV-⌬N␤cat] mice. The SP cell fraction (a progenitor-enriched fraction) is increased in both [MMTV-Wnt1] and [MMTV-⌬N␤cat] mammary glands in vivo and after just 60 h of treatment of primary cultures of MECs with the Wnt3A ligand. This specific growth͞survival stimulus is inhibited by the addition of the canonical (lipoprotein receptor- The growth of the total MEC population was not, however, affected by these supplements. Averages and SDs were from triplicate determinations. Fig. 4 . Transgenic MECs expressing the oncogene ⌬N␤cat colonized mammary fat pads more efficiently than control cells. MECs were isolated from [⌬N␤cat]-transgenic and control mice and counted; then several inocula containing different numbers of cells were transferred to cleared fat pads to test their progenitor potential. The fraction of cleared mammary fat pads colonized by cells was scored. For experiment 1, cells were transferred after the cell preparation was substantially reduced to single cells by enzymatic dissociation, a procedure that tends to impair viability. For experiment 2, cells were transferred in the clusters typical of our standard preparation of MECs. The results were substantially the same and showed that the progenitor activity in MEC populations from [⌬N␤cat]-glands was higher than normal. Numbers in parentheses represent the number of glands colonized per total number of glands transplanted. The morphogenesis of outgrowths from 50,000 cell inocula is also shown. related protein-dependent) Wnt pathway inhibitor dkk1 (31), suggesting that ␤-catenin͞TCF-induced transactivation is responsible for the progenitor-specific responses. Data from two other mouse strains suggests that Wnt signaling is involved in the division and survival of lobuloalveolar progenitors. Thus, when ␤-catenin͞T cell factor signaling was inhibited by expression of a dominant negative ␤-catenin (a ␤ catenin-engrailed fusion protein driven by MMTV or whey acidic protein) (33) or the Wnt canonical pathway inhibitor axin (driven by an inducible MMTV construct) (34) , there was transient apoptosis followed by significant developmental attrition, consistent with the loss of a progenitor population. Another group (28) has recently shown that a keratin 6-, Sca-1-positive cell fraction likely to be progenitor-enriched is amplified only in transgenic mammary glands from strains expressing Wnt effectors and not other oncogenes, such as polyoma middle T, H-Ras, or Neu. Thus, although these other oncogenes also induce hyperplasia and dysregulated growth, the preneoplastic mammary glands are not associated with an increased proportion of immature cells.
Data from other groups also suggests that the continuous presence of Wnt effectors is required to maintain Wnt-induced cells. Gunther et al. (35) showed that if Wnt1 expression was withdrawn from a transgenic mouse with a doxycyclineinducible, MMTV-driven Wnt1 construct, tumors regressed within 10 days. Furthermore, when Wnt signaling was inhibited in LS174T colon cancer cells, their growth was arrested (36) . We suggest that the transcriptional context of stem cells is unique and that the mitogenic effects of ␤-catenin͞T cell factor-induced transactivation are only expressed in this context. We propose that mammary progenitor dysregulation initiates Wnt-induced tumor development and that the tumor precursor cell is drawn from this subpopulation.
In support of this hypothesis, a tumor-resistant mouse strain with a null mutation in Sdc1 contains just 50% of the normal SP fraction, and this reduction correlates with reduced branching complexity at all stages of outgrowth of the mammary tree. This implies that during ductal extension, mammary branching may be regulated by stem cell number͞activity. We do not yet understand why mammary development in Sdc1 Ϫ/Ϫ mice is hypomorphic, but it is unlikely to be related directly to the activity of the Wnt-receptor signaling complex (19) . However, when these SP-deficient mice are crossed with those that accumulate mammary progenitors, the SP fraction is intermediate, the preneoplastic hyperplasia is reduced, and the onset of tumor development is slowed. Thus, the higher the fraction of progenitor͞stem cells, the more likely subsequent mutation will induce tumor development. Note that for 90% of human breast tumor samples tested, Al-Hajj et al. (37) showed that the tumor-forming potential resides in a morphologically undifferentiated, karyotypically diploid subfraction that contains the tumor growth potential and recreates the karyotypically abnormal majority after xenografting at limiting dilution. This group concluded that tumor growth is likely to be driven by the division of tumor stem cells that are related in some way to the normal stem cell compartment.
The accumulation of stem cells in Wnt-effector-induced mammary glands is associated with morphogenic hyperplasia. We propose that this hyperplasia, or disrupted ductal architecture, is the result of the accumulation of relatively undifferentiated, progenitor and transit-amplifying cells. However, the ductal density does not exceed the normal range, and we deduce that the mechanisms that govern mammary cell density during normal development are still intact (38) . Genetic changes that have been shown to cooperate during progression in this mouse model include the up-regulation of mitogens, such as fibroblast growth (19) . This cohort was of mixed-strain background (a BALB/c͞FVB backcross). SP cells were separated by flow cytometry, and the results are presented as percent SP cells relative to ⌬N␤cat Ϫ/Ϫ ; Sdc1 ϩ/ϩ mice. The average and SD were generated from three independent sorts.
factor (26, 27) or tumor growth factor ␣ (39). We propose that mutations in bipotential progenitor cells that allow differentiated progeny to escape growth inhibition will cooperate to transform these hyperplastic outgrowths into a tumor. Thus, the brakes that slow the division of mature cells in virgin glands would be removed and the proliferation of all cells in this lineage maximized. In support of this idea, we find that the SP fraction in tumors declines to a fraction typical of a normal population profile. This trend was also apparent for the tumor progression profiles reported by Li et al. (28) .
Few human breast tumors have the same properties of rapid growth together with bilineal differentiation that is typical of tumors that evolve in this mouse model. However, tumor evolution in [MMTV-Wnt1]-mice was different in a p53 Ϫ/Ϫ background; tumors arose earlier, grew faster, were more anaplastic, and showed reduced expression of differentiated markers (25) . Thus, they resembled their human counterparts more faithfully. Furthermore, myoepithelial ''basal'' markers are expressed by some of the cells in up to one-fifth of human breast cancers, implying that there is at least residual expression of both mammary lineages. These tumors fell into a separate class according to transcriptional profiling data (40, 41) , and we propose that this phenotype is consistent with a bipotential stem cell origin.
In summary, we propose that factors that regulate progenitor division also regulate susceptibility to tumor development. This hypothesis is consistent with a model that includes a relatively mutable, long-lived progenitor cell. We infer that measurement of progenitor fractions of human breast samples (and especially of lesions considered to be preneoplastic) may be an excellent prognostic for assessing risk of progression. We also infer that stem cell technologies that rely on amplification of these mutable progenitor cell types may be especially prone to subsequent tumor development and that this risk factor should be carefully evaluated before the widespread adoption of, for example, neural stem cell transplants.
